Several studies have highlighted the role of pro-inflammatory cytokines such as IL-1β and TNF-α in this process. These cytokines, upregulated during periodontal infections, can promote a pro-inflammatory environment in the brain, contributing to AD-like pathology and cognitive dysfunctions.[1]
Porphyromonas gingivalis, a key pathogen in periodontitis, has been shown to induce systemic inflammation, amyloid β protein deposition, and tau protein hyperphosphorylation, leading to AD-like lesions. This pathogen can alter gut microbiota and disrupt the gut-brain axis, further exacerbating AD pathology.[2] Additionally, bacterial membrane vesicles from P. gingivalis can cross the blood-brain barrier, initiating physiological changes associated with AD.[3]
Moreover, chronic systemic exposure to P. gingivalis lipopolysaccharide (PgLPS) has been shown to promote neuroinflammation and tau hyperphosphorylation in animal models, leading to cognitive deficits.[4] The presence of periodontal pathogens in the brain, such as P. gingivalis, has been detected in autopsy specimens from individuals with AD, suggesting a direct microbial involvement in AD pathogenesis.[5]
In summary, the link between gum disease and Alzheimer's disease is supported by evidence of systemic inflammation, direct microbial invasion, and the resultant neuroinflammatory and neurodegenerative processes.
1. IL-1β and TNF-α Play an Important Role in Modulating the Risk of Periodontitis and Alzheimer's Disease.
Wang RP, et al. J. Neuroinflammation. 2023;20(1):71. doi:10.1186/s12974-023-02747-4.
2. Porphyromonas Gingivalis Induces Disturbance of Kynurenine Metabolism Through the Gut-Brain Axis: Implications for Alzheimer's Disease.
Zhu H, et al. J. Dental Research. 2025;:220345241303141. doi:10.1177/00220345241303141.
3. Bacterial Membrane Vesicles: The Missing Link Between Bacterial Infection and Alzheimer Disease. Butler CA, et al.
The Journal of Infectious Diseases. 2024;230(Supplement_2):S87-S94. doi:10.1093/infdis/jiae228.
4. GSK3β Is Involved in Promoting Alzheimer's Disease Pathologies Following Chronic Systemic Exposure to Porphyromonas Gingivalis Lipopolysaccharide in Amyloid Precursor Protein Knock-in Mice. Jiang M, et al.
Brain, Behavior, and Immunity. 2021;98:1-12. doi:10.1016/j.bbi.2021.08.213.
5.Porphyromonas Gingivalis and Alzheimer Disease: Recent Findings and Potential Therapies.
Ryder MI. Journal of Periodontology. 2020;91 Suppl 1:S45-S49. doi:10.1002/JPER.20-0104
No comments:
Post a Comment